Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma

Abstract Background Liquid-liquid phase separation (LLPS) is essential for the formation of membraneless organelles and significantly influences cellular compartmentalization, chromatin remodeling, and gene regulation. Previous research has highlighted the critical function of liquid-liquid biopolym...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianhao Li, Han Chen, Lang Bai, Hong Tang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Biology Direct
Subjects:
Online Access:https://doi.org/10.1186/s13062-025-00592-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544914329927680
author Jianhao Li
Han Chen
Lang Bai
Hong Tang
author_facet Jianhao Li
Han Chen
Lang Bai
Hong Tang
author_sort Jianhao Li
collection DOAJ
description Abstract Background Liquid-liquid phase separation (LLPS) is essential for the formation of membraneless organelles and significantly influences cellular compartmentalization, chromatin remodeling, and gene regulation. Previous research has highlighted the critical function of liquid-liquid biopolymers in the development of hepatocellular carcinoma (HCC). Methods This study conducted a comprehensive review of 3,685 liquid-liquid biopolymer regulators, leading to the development of a LLPS related Prognostic Risk Score (LPRS) for HCC through bootstrap-based univariate Cox, Random Survival Forest (RSF), and LASSO analyses. A prognostic nomogram for HCC patients was developed using LPRS and other clinicopathological factors. We utilized SurvSHAP to identify key genes within the LPRS influencing HCC prognosis. To validate our findings, we collected 49 HCC cases along with adjacent tissue samples and confirmed the correlation between DCAF13 expression and HCC progression through qRT-PCR analysis and in vitro experiments. Results LPRS was established with 8 LLPS-related genes (TXN, CBX2, DCAF13, SLC2A1, KPNA2, FTCD, MAPT, and SAC3D1). Further research indicated that a high LPRS is closely associated with vascular invasion, histological grade (G3-G4), and TNM stage (III-IV) in HCC, concurrently establishing LPRS as an independent risk factor for prognosis. A nomogram that integrates LPRS with TNM staging and patient age markedly improves the predictive accuracy of survival outcomes for HCC patients. Our findings suggest that increased DCAF13 expression in HCC plays a crucial role in cancer progression and angiogenesis. Navitoclax has emerged as a promising treatment for HCC patients with high LPRS levels, offering a novel therapeutic direction by targeting LLPS. Conclusion We have formulated a novel LPRS model that is capable of accurately predicting the clinical prognosis and drug sensitivity of HCC. DCAF13 might play a pivotal role in malignant progression mediated by LLPS.
format Article
id doaj-art-f208547203cf4a4dabf7bf84e63bcf48
institution Kabale University
issn 1745-6150
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Biology Direct
spelling doaj-art-f208547203cf4a4dabf7bf84e63bcf482025-01-12T12:11:28ZengBMCBiology Direct1745-61502025-01-0120111610.1186/s13062-025-00592-4Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinomaJianhao Li0Han Chen1Lang Bai2Hong Tang3Center of Infectious Diseases, West China Hospital of Sichuan UniversityCenter of Infectious Diseases, West China Hospital of Sichuan UniversityCenter of Infectious Diseases, West China Hospital of Sichuan UniversityCenter of Infectious Diseases, West China Hospital of Sichuan UniversityAbstract Background Liquid-liquid phase separation (LLPS) is essential for the formation of membraneless organelles and significantly influences cellular compartmentalization, chromatin remodeling, and gene regulation. Previous research has highlighted the critical function of liquid-liquid biopolymers in the development of hepatocellular carcinoma (HCC). Methods This study conducted a comprehensive review of 3,685 liquid-liquid biopolymer regulators, leading to the development of a LLPS related Prognostic Risk Score (LPRS) for HCC through bootstrap-based univariate Cox, Random Survival Forest (RSF), and LASSO analyses. A prognostic nomogram for HCC patients was developed using LPRS and other clinicopathological factors. We utilized SurvSHAP to identify key genes within the LPRS influencing HCC prognosis. To validate our findings, we collected 49 HCC cases along with adjacent tissue samples and confirmed the correlation between DCAF13 expression and HCC progression through qRT-PCR analysis and in vitro experiments. Results LPRS was established with 8 LLPS-related genes (TXN, CBX2, DCAF13, SLC2A1, KPNA2, FTCD, MAPT, and SAC3D1). Further research indicated that a high LPRS is closely associated with vascular invasion, histological grade (G3-G4), and TNM stage (III-IV) in HCC, concurrently establishing LPRS as an independent risk factor for prognosis. A nomogram that integrates LPRS with TNM staging and patient age markedly improves the predictive accuracy of survival outcomes for HCC patients. Our findings suggest that increased DCAF13 expression in HCC plays a crucial role in cancer progression and angiogenesis. Navitoclax has emerged as a promising treatment for HCC patients with high LPRS levels, offering a novel therapeutic direction by targeting LLPS. Conclusion We have formulated a novel LPRS model that is capable of accurately predicting the clinical prognosis and drug sensitivity of HCC. DCAF13 might play a pivotal role in malignant progression mediated by LLPS.https://doi.org/10.1186/s13062-025-00592-4Hepatocellular carcinomaLiquid–liquid phase separationDCAF13Tumor microenvironmentPrognosis
spellingShingle Jianhao Li
Han Chen
Lang Bai
Hong Tang
Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
Biology Direct
Hepatocellular carcinoma
Liquid–liquid phase separation
DCAF13
Tumor microenvironment
Prognosis
title Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
title_full Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
title_fullStr Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
title_full_unstemmed Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
title_short Utilizing liquid-liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
title_sort utilizing liquid liquid biopolymer regulators to predict the prognosis and drug sensitivity of hepatocellular carcinoma
topic Hepatocellular carcinoma
Liquid–liquid phase separation
DCAF13
Tumor microenvironment
Prognosis
url https://doi.org/10.1186/s13062-025-00592-4
work_keys_str_mv AT jianhaoli utilizingliquidliquidbiopolymerregulatorstopredicttheprognosisanddrugsensitivityofhepatocellularcarcinoma
AT hanchen utilizingliquidliquidbiopolymerregulatorstopredicttheprognosisanddrugsensitivityofhepatocellularcarcinoma
AT langbai utilizingliquidliquidbiopolymerregulatorstopredicttheprognosisanddrugsensitivityofhepatocellularcarcinoma
AT hongtang utilizingliquidliquidbiopolymerregulatorstopredicttheprognosisanddrugsensitivityofhepatocellularcarcinoma